AI Multi-Omics Analytics Market Global Assessment Report 2026 to 2035

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI Multi-Omics Analytics Market Size, Share & Trends Analysis Report by Offering (Software Platforms, Analytics Services), by Omics Data Type (Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics, Others), by AI Technology (Machine Learning, Deep Learning, Others), by Application (Drug Discovery and Development, Biomarker Discovery, Clinical Diagnostics and Precision Medicine, Others), by End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospitals and Clinical Laboratories, Contract Research Organizations (CROs), Others),-Market Outlook And Industry Analysis 2035"

AI Multi-Omics Analytics Market Size is valued at USD 0.99 Bn in 2025 and is predicted to reach USD 11.67 Bn by the year 2035 at a 28.2% CAGR during the forecast period for 2026 to 2035.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com//request-sample/3786

At the intersection of artificial intelligence and life sciences, AI multi-omics analytics is changing how researchers study diseases, discover new drugs, and develop personalised healthcare. By bringing together data from genomics, transcriptomics, proteomics, metabolomics, and epigenomics, these tools give a fuller picture of biological systems and reveal patterns that might be missed when looking at each dataset alone. The market includes AI-driven software, analytical tools, and services that help with biomedical research, biomarker discovery, clinical diagnostics, and drug development.

The market is gaining momentum as pharmaceutical companies, biotech firms, and research institutions seek faster, more accurate, and data-driven approaches to understanding complex diseases. Advances in machine learning, deep learning, and computational biology help researchers handle large amounts of biological data, identify potential treatment targets, and improve personalised therapies.

At the same time, more investment in life sciences, better access to multi-omics data, and more partnerships between tech companies and healthcare groups are opening up new chances for growth. These changes make AI multi-omics analytics an important tool for advancing precision medicine and accelerating innovation in healthcare and biotech.

List of Prominent Players in the AI Multi-Omics Analytics Market:
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• QIAGEN N.V.
• Agilent Technologies, Inc.
• SOPHiA GENETICS SA
• DNAnexus, Inc.
• Tempus AI, Inc.
• Owkin, Inc.
• Recursion Pharmaceuticals, Inc.
• Athos Therapeutics, Inc.

Add our site to Google Preferred Sources for quality content: https://google.com/preferences/source?q=insightaceanalytic.com

Drivers:
The AI multi-omics analytics market is expanding as more pharmaceutical companies, biotech firms, and research groups look for quicker and better ways to understand complex diseases and create targeted treatments. By bringing together data from genomics, transcriptomics, proteomics, metabolomics, and epigenomics, AI-powered analytics helps researchers spot disease patterns, find biomarkers, and support drug development.

New advances in machine learning, deep learning, and computational biology make it easier to handle large amounts of biological data and find insights that traditional methods might miss. More investment in precision medicine, higher demand for personalised healthcare, and greater use of AI in life sciences are also opening up new growth opportunities.

Challenges:
The AI multi-omics analytics market faces several challenges, especially in combining and interpreting complex biological data from different technologies. Differences in data formats, quality, and how measurements are taken can affect how accurate and reliable the results are. Building and using AI-powered platforms can also be expensive because they require powerful computing systems, software, data management, and skilled experts. Limited access to high-quality datasets, worries about patient data privacy, and the need to check AI-generated results can also slow adoption. It's important to make sure these technologies give consistent, reliable, and clinically meaningful results, particularly when their findings are used to support drug development and clinical decisions.

Regional Trends:
North America is expected to maintain a leading position in the AI multi-omics analytics market, supported by its established biotechnology and pharmaceutical sectors, advanced research facilities, and big investments in AI and life sciences. The region has major genomics companies, AI providers, research groups, and healthcare organisations that are using more data-driven methods in biomedical research.

Partnerships among pharmaceutical companies, biotech firms, and tech developers are advancing AI-powered drug discovery, biomarker identification, and precision medicine. More research funding, better access to multi-omics data, and new analytical tools are also driving market growth. At the same time, Europe and Asia Pacific are also growing, with more life sciences research, healthcare innovation, and investment in AI-driven biotech.

Customize this Study according to your Requirements @ https://www.insightaceanalytic.com/customization/3786

Key Development
• In January 2026, Thermo Fisher Scientific announced a strategic collaboration with NVIDIA to develop AI-based solutions and laboratory automation capabilities, aiming to improve laboratory accuracy, speed, and workflow efficiency.
• In May 2026, DNAnexus announced new AI-driven capabilities and solution packages for precision health, strengthening its platform for analyzing complex omics data and supporting the development and deployment of AI models in biomedical research.

Segmentation of AI Multi-Omics Analytics Market-
By Offering-
• Software Platforms
• Analytics Services
By Omics Data Type-
• Genomics
• Transcriptomics
• Proteomics
• Metabolomics
• Epigenomics
• Others
By AI Technology-
• Machine Learning
• Deep Learning
• Others
By Application-
• Drug Discovery and Development
• Biomarker Discovery
• Clinical Diagnostics and Precision Medicine
• Others
By End User-
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Hospitals and Clinical Laboratories
• Contract Research Organizations (CROs)
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Comprehensive Report Overview: https://www.insightaceanalytic.com/report/ai-multi-omics-analytics-market/3786

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.